Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide—Neisseria meningitidis outer membrane protein conjugate vaccine

This publication has 23 references indexed in Scilit:

• Antibody Responses to Haemophilus influenzae Type b Polysaccharide Vaccine in Relation to Km(1) and G2m(23) Immunoglobulin Allotypes
  The Journal of Infectious Diseases, 1986
• Persistence of antibody and response to booster dose of Haemophilus influenzae type b polysaccharide diphtheria toxoid conjugate vaccine in infants immunized at 9 to 15 months of age
  The Journal of Pediatrics, 1986
• Prospects for Prevention of Haemophilus influenzae Type b Disease by Immunization
  The Journal of Infectious Diseases, 1986
• Haemophilus influenzae type b polysaccharide vaccines
  The Journal of Pediatrics, 1985
• Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b
  The Journal of Pediatrics, 1985
• ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINE
  The Lancet, 1985
• Safety and immunogenicity of haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age
  The Journal of Pediatrics, 1985
• Immunogenicity of Haemophilus influenzae type b polysaccharide—diphtheria toxoid conjugate vaccine in adults
  The Journal of Pediatrics, 1984
• Thymus-independent antigens: complexity of B-lymphocyte activation revealed
  Immunology Today, 1982
• Human Serum Activities against Hemophilus influenzae, Type b
  Journal of Clinical Investigation, 1972